NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,828,334 | +559.1% | 615,418 | +771.8% | 0.01% | +500.0% |
| Q2 2023 | $1,794,499 | +7668.7% | 70,594 | -89.0% | 0.00% | -92.3% |
| Q1 2023 | $23,099 | -36.6% | 638,974 | -30.6% | 0.01% | -35.0% |
| Q4 2022 | $36,450 | -99.7% | 920,448 | +226.7% | 0.02% | +150.0% |
| Q3 2022 | $13,129,000 | +111.9% | 281,730 | +228.8% | 0.01% | +166.7% |
| Q1 2022 | $6,197,000 | -49.0% | 85,674 | -42.8% | 0.00% | -57.1% |
| Q4 2021 | $12,145,000 | -25.5% | 149,815 | +6.9% | 0.01% | -30.0% |
| Q3 2021 | $16,303,000 | +142.2% | 140,080 | +245.0% | 0.01% | +150.0% |
| Q2 2021 | $6,732,000 | +44.6% | 40,603 | +21.7% | 0.00% | +33.3% |
| Q1 2021 | $4,654,000 | -63.0% | 33,363 | -54.0% | 0.00% | -66.7% |
| Q4 2020 | $12,566,000 | -67.0% | 72,591 | -73.4% | 0.01% | -80.9% |
| Q3 2020 | $38,040,000 | +133.6% | 273,077 | +100.3% | 0.05% | +113.6% |
| Q2 2020 | $16,287,000 | +2468.9% | 136,327 | +2049.9% | 0.02% | +2100.0% |
| Q1 2020 | $634,000 | -97.4% | 6,341 | -96.9% | 0.00% | -96.7% |
| Q4 2019 | $24,351,000 | +333.3% | 207,173 | +216.9% | 0.03% | +233.3% |
| Q3 2019 | $5,620,000 | -54.0% | 65,380 | -65.3% | 0.01% | -50.0% |
| Q2 2019 | $12,229,000 | -82.4% | 188,628 | -83.0% | 0.02% | -82.7% |
| Q1 2019 | $69,443,000 | +40.4% | 1,110,912 | -12.7% | 0.10% | +35.1% |
| Q4 2018 | $49,468,000 | -8.2% | 1,271,979 | +34.5% | 0.08% | +16.7% |
| Q3 2018 | $53,910,000 | +6.4% | 945,782 | +61.8% | 0.07% | -2.9% |
| Q1 2018 | $50,661,000 | +1545.9% | 584,529 | +1211.2% | 0.07% | +1600.0% |
| Q4 2017 | $3,078,000 | -95.8% | 44,581 | -94.4% | 0.00% | -96.4% |
| Q3 2017 | $72,737,000 | +1.7% | 800,360 | -16.7% | 0.11% | -13.3% |
| Q2 2017 | $71,538,000 | +138.4% | 961,148 | +200.1% | 0.13% | +132.7% |
| Q1 2017 | $30,006,000 | -20.5% | 320,232 | -38.4% | 0.06% | -30.4% |
| Q4 2016 | $37,743,000 | -35.5% | 519,455 | -7.3% | 0.08% | -20.2% |
| Q3 2016 | $58,476,000 | +112.7% | 560,172 | +50.3% | 0.10% | +57.1% |
| Q2 2016 | $27,498,000 | +10.0% | 372,811 | -16.1% | 0.06% | +1.6% |
| Q1 2016 | $24,991,000 | +19.0% | 444,201 | +42.8% | 0.06% | +40.9% |
| Q4 2015 | $20,998,000 | +882.1% | 311,037 | +597.3% | 0.04% | +1000.0% |
| Q1 2015 | $2,138,000 | +482.6% | 44,605 | +369.5% | 0.00% | +300.0% |
| Q4 2014 | $367,000 | – | 9,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |